ADC Case Study Anti-HER2 ADC Preparation & Potency Evaluation Against HER2 Overexpression Human Cancer Cell Line
Read

ADC Case Study Anti-HER2 ADC Preparation & Potency Evaluation Against HER2 Overexpression Human Cancer Cell Line

by CreativeBiolabs

ADCs are novel immunotherapeutic agents that are comprised of an antibody, a toxic payload, and a small molecule linker that covalently bridges the other components. With years of experience in providing ADC related products and services, Creative Biolabs... More

Read the publication